IBOHealthcareMicro-Cap
IMPACT BIOMEDICAL INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for IMPACT BIOMEDICAL INC. (IBO), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are IBO insiders buying or selling?
IMPACT BIOMEDICAL INC. insiders reported 5 open-market buys ($160.7K) and 11 sells ($7.5M) across 16 Form 4 filings — a net selling position of $7.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 31, 2026)
Total Form 4 filings
16
SEC EDGAR
Insider filers
5
Insider buys (5)
$160.7K
Insider sells (11)
$7.5M
Insider sentiment
Net sellingNet insider flow of $7.3M in net selling.
Recent IBO insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Todd D Macko | Chief Financial Officer | Sale | 45.0K | $0.56 | $25.3K |
| Mar 25, 2026 | Jason Grady | Director | Sale | 50.0K | $0.65 | $32.5K |
| Jan 6, 2026 | DSS, INC. | 10% Owner | Sale | 161.0K | $0.55 | $88.0K |
| May 27, 2025 | DSS, INC. | 10% Owner | Sale | 161.0K | $0.55 | $88.0K |
| Apr 8, 2025 | DSS, INC. | 10% Owner | Sale | 890.8K | $0.95 | $845.0K |
| Apr 7, 2025 | Heng Fai Ambrose Chan | Director | Sale | 351.6K | $0.50 | $174.0K |
| Apr 4, 2025 | Heng Fai Ambrose Chan | Director, 10% Owner | Sale | 1.7M | $0.66 | $1.1M |
| Apr 3, 2025 | Heng Fai Ambrose Chan | Director, 10% Owner | Sale | 2.5M | $1.15 | $2.9M |
| Mar 28, 2025 | DSS, INC. | 10% Owner | Sale | 605.6K | $3.22 | $2.0M |
| Mar 25, 2025 | DSS, INC. | 10% Owner | Sale | 53.1K | $4.69 | $249.1K |
| Dec 9, 2024 | Frank D Heuszel | Chief Executive Officer | Purchase | 500 | $2.26 | $1.1K |
| Dec 4, 2024 | Frank D Heuszel | Chief Executive Officer | Purchase | 500 | $2.61 | $1.3K |
| Dec 4, 2024 | Frank D Heuszel | Chief Executive Officer | Purchase | 1.1K | $2.61 | $2.7K |
| Nov 22, 2024 | DSS, INC. | 10% Owner | Sale | 5.7K | $2.99 | $17.0K |
| Sep 19, 2024 | DSS, INC. | 10% Owner | Purchase | 1.0K | $2.33 | $2.3K |
| Sep 19, 2024 | DSS, INC. | 10% Owner | Purchase | 57.8K | $2.65 | $153.2K |
Showing the 16 most recent of 16 Form 4 filings for IMPACT BIOMEDICAL INC..
Most active IBO insiders
- DSS, INC.8 filings
- Frank D Heuszel3 filings
- Heng Fai Ambrose Chan3 filings
- Jason Grady1 filing
- Todd D Macko1 filing
Ask anything about IBO insider activity
Use Trabud's AI agent to query IMPACT BIOMEDICAL INC.'s Form 4 history in plain English — "Show me IBO CEO purchases this year" or compare it against any other ticker.
Open the AI agentIBO insider trading FAQ
Are IMPACT BIOMEDICAL INC. insiders buying or selling?
Across 16 SEC Form 4 filings, IMPACT BIOMEDICAL INC. (IBO) insiders reported 5 open-market purchases totaling $160.7K and 11 sales totaling $7.5M. That is a net selling position of $7.3M.
How many insiders trade IBO stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for IMPACT BIOMEDICAL INC.. The most recent filing was accepted on Mar 31, 2026.
Where does Trabud get IBO insider trading data?
All IBO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.